137: Dr. Joan Mannick - Targeting mTOR to Improve Immune Function and Healthspan
About this episode
What if targeting a single cellular pathway could slow aging and boost immunity?
Dr. Joan Mannick, a leading voice in aging science, reveals how mTOR inhibitors may be the future of longevity therapeutics. From her early inspiration to groundbreaking clinical trials, Dr. Mannick explores the role of mTOR in aging, immune response, and antiviral immunity. Learn how selective mTOR inhibition could extend healthspan without compromising muscle mass, improve vaccine response in older adults, and unlock new possibilities in clinical longevity.
Learn more about Dr. Joan Mannick:
https://www.linkedin.com/in/joan-mannick-8089a614/
-
Download Dr. Buck Joffrey's FREE ebook, Living Longer for Busy People: https://ru01tne2.pages.infusionsoft.net/?affiliate=0
Book a FREE longevity coaching consultation with Dr. Buck Joffrey: https://coaching.longevityroadmap.com/
Get every episode summarized
Each time Longevity Roadmap publishes, we email you a written briefing from the transcript — the topics, who appeared, and any specific claims, with the ad reads skipped.
Email me new episodesFree for 3 shows. No card needed.
Hosts & guests
No transcript yet
This episode has not been transcribed. Request it and it moves to the front of the queue.
More episodes
More from Longevity Roadmap
169: Protein Folding Errors Contribute to Aging and Disease
Longevity Roadmap
168: Best of 2025
Longevity Roadmap
167: Why Bats Don't Age and Why You Should Care with Dr. Emma Teeling
Longevity Roadmap
166: BioXcellerator - The Cutting Edge of Stem Cell Therapy
Longevity Roadmap